- Home
- DBVT vs ILPT Comparison
DBVT vs ILPT Comparison
Compare DBVT & ILPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DBVT
- ILPT
- Stock Information
- Founded
- DBVT 2002
- ILPT 2017
- Country
- DBVT France
- ILPT United States
- Employees
- DBVT N/A
- ILPT N/A
- Industry
- DBVT Biotechnology: Biological Products (No Diagnostic Substances)
- ILPT Real Estate Investment Trusts
- Sector
- DBVT Health Care
- ILPT Real Estate
- Exchange
- DBVT Nasdaq
- ILPT Nasdaq
- Market Cap
- DBVT 237.4M
- ILPT 217.6M
- IPO Year
- DBVT N/A
- ILPT 2018
- Fundamental
- Price
- DBVT $9.40
- ILPT $4.75
- Analyst Decision
- DBVT Buy
- ILPT Buy
- Analyst Count
- DBVT 4
- ILPT 2
- Target Price
- DBVT $14.81
- ILPT $10.00
- AVG Volume (30 Days)
- DBVT 41.9K
- ILPT 433.3K
- Earning Date
- DBVT 07-29-2025
- ILPT 07-29-2025
- Dividend Yield
- DBVT N/A
- ILPT 0.84%
- EPS Growth
- DBVT N/A
- ILPT N/A
- EPS
- DBVT N/A
- ILPT N/A
- Revenue
- DBVT $3,497,000.00
- ILPT $441,992,000.00
- Revenue This Year
- DBVT $1,700.53
- ILPT $3.09
- Revenue Next Year
- DBVT $535.67
- ILPT $1.79
- P/E Ratio
- DBVT N/A
- ILPT N/A
- Revenue Growth
- DBVT N/A
- ILPT 0.61
- 52 Week Low
- DBVT $2.21
- ILPT $2.45
- 52 Week High
- DBVT $12.78
- ILPT $5.45
- Technical
- Relative Strength Index (RSI)
- DBVT 52.73
- ILPT 79.82
- Support Level
- DBVT $9.00
- ILPT $3.35
- Resistance Level
- DBVT $10.12
- ILPT $4.83
- Average True Range (ATR)
- DBVT 0.57
- ILPT 0.24
- MACD
- DBVT 0.08
- ILPT 0.15
- Stochastic Oscillator
- DBVT 72.24
- ILPT 96.36
About DBVT DBV Technologies S.A.
DBV Technologies SA is a clinical-stage specialty biopharmaceutical company focused on changing the field of immunotherapy by developing a novel technology platform called Viaskin. The therapeutic approach is based on epicutaneous immunotherapy or EPIT, its proprietary method of delivering biologically active compounds to the immune system through intact skin using Viaskin, an epicutaneous patch (i.e., a skin patch). Its main product candidate under development is Viaskin Peanut for the treatment of peanut-allergic patients. In addition, the company also has earlier-stage food allergy programs, including Viaskin Milk and Eosinophilic Esophagitis, or EoE.
About ILPT Industrial Logistics Properties Trust of Beneficial Interest
Industrial Logistics Properties Trust is a real estate investment trust. It owns and leases industrial and logistics properties throughout the United States. The company's investment portfolio includes industrial lands in Hawaii and industrial and logistics properties in other states. Rental revenue is earned from Hawaii Properties and Mainland Properties.